Lensar (LNSR) Cash from Operations (2019 - 2026)
Lensar (LNSR) reported Cash from Operations of 4271000.0 for Q1 2026, up 38.44% year-over-year from 3085080.48 in Q1 2025, and down 791.1% on a QoQ basis from 618000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Cash from Operations data on file, last reported at 4271000.0 in Q1 2026.
- Quarterly Cash from Operations rose 38.44% year-over-year to 4271000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12164000.0 (down 211.42% YoY) and the FY2025 annual result came in at 14831000.0, down 551.91% from the prior year.
- Cash from Operations fell to 4271000.0 in Q1 2026 per LNSR's latest filing, from 618000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3657000.0 in Q4 2024 and bottomed at 6938000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 3513000.0 (2025), against an average of 2699529.41.
- The widest annual swing landed in 2022, when Cash from Operations slumped 543.84%; it then soared 1030.09% in 2024.
- Tracing LNSR's Cash from Operations over 5 years: stood at 4758000.0 in 2022, then soared by 89.91% to 480000.0 in 2023, then surged by 861.88% to 3657000.0 in 2024, then sank by 83.1% to 618000.0 in 2025, then sank by 791.1% to 4271000.0 in 2026.
- Per Business Quant, the three latest LNSR Cash from Operations figures stand at 4271000.0 (Q1 2026), 618000.0 (Q4 2025), and 3513000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | 618,000.00 |
| Dec 31, 2025 | 618,000.00 |
| Sep 30, 2025 | -3.51 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | -3.78 Mn |
| Jun 30, 2024 | -3.78 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Dec 31, 2023 | -480,000.00 |
| Dec 31, 2023 | -480,000.00 |
| Sep 30, 2023 | -339,000.00 |
| Sep 30, 2023 | -339,000.00 |
| Jun 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -2.14 Mn |
| Mar 31, 2023 | -6.70 Mn |
| Mar 31, 2023 | -6.70 Mn |
| Dec 31, 2022 | -4.76 Mn |
| Dec 31, 2022 | -4.76 Mn |
| Sep 30, 2022 | -4.70 Mn |
| Sep 30, 2022 | -4.70 Mn |
| Jun 30, 2022 | -2.79 Mn |
| Jun 30, 2022 | -2.79 Mn |
| Mar 31, 2022 | -2.61 Mn |
| Mar 31, 2022 | -2.61 Mn |
| Dec 31, 2021 | -739,000.00 |
| Dec 31, 2021 | -739,000.00 |
| Sep 30, 2021 | -2.15 Mn |
| Sep 30, 2021 | -2.15 Mn |
| Jun 30, 2021 | -1.46 Mn |
| Jun 30, 2021 | -1.46 Mn |
| Mar 31, 2021 | -4.62 Mn |
| Mar 31, 2021 | -4.62 Mn |
| Dec 31, 2020 | -2.00 Mn |
| Dec 31, 2020 | -2.00 Mn |
| Sep 30, 2020 | -55,000.00 |
| Sep 30, 2020 | -55,000.00 |
| Jun 30, 2020 | -5.38 Mn |
| Jun 30, 2020 | -5.38 Mn |
| Mar 31, 2020 | -6.36 Mn |
| Mar 31, 2020 | -6.36 Mn |
| Dec 31, 2019 | -6.78 Mn |
| Dec 31, 2019 | -6.78 Mn |